Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Página 1 a partir de 24 resultados
Treating myocardial infarction by administration of a thrombolytic agent together with adenosine
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective
A1 adenosine receptor agonists
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including modifying cardiac activity, in particular treatment of arrhythmia. The compounds are also
Method for promoting angiogenesis using heparin and adenosine
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to a method for promoting the growth of new blood vessels (angiogenesis) especially coronary blood vessels after myocardial infarction.
BACKGROUND OF THE INVENTION
It is estimated that five million people are afflicted with chronic stable angina
A.sub.1 adenosine receptor agonists
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including modifying cardiac activity, in particular treatment of arrhythmia. The compounds are also useful for
A.sub.1 adenosine receptor agonists
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including modifying cardiac activity, in particular treatment of arrhythmia. The compounds are also
A.sub.1 adenosine receptor agonists
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to the preparation of compounds that are partial or full A.sub.1 adenosine receptor agonists. The compounds are useful for treating mammals with diabetic disorders, obesity, modifying adipocyte function, CNS disorders, and modifying cardiac
Partial and full agonists of A1 adenosine receptors
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including modifying cardiac activity, in particular treatment of arrhythmia. The compounds are also
Allosteric modulators of the A.sub.1 adenosine receptor
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to 2-aminothiophene derivatives, pharmaceutical compositions containing them, and to methods of treating conditions mediated by the A.sub.1 adenosine receptor including pain, in particular, chronic pain such as neuropathic pain, cardiac disease or disorder such as
Allosteric modulators of the A.sub.1 adenosine receptor
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to 2-aminothiophene derivatives, pharmaceutical compositions containing them, and to methods of treating conditions mediated by the A.sub.1 adenosine receptor including pain, in particular, chronic pain such as neuropathic pain, cardiac disease or disorder such as
Partial and full agonists of A1 adenosine receptors
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to the preparation of compounds that are partial or full A.sub.1 adenosine receptor agonists. The compounds are useful for treating mammals with diabetic disorders, obesity, modifying adipocyte function, CNS disorders, and modifying cardiac
Partial and full agonists of A.sub.1 adenosine receptors
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including modifying cardiac activity, in particular treatment of arrhythmia. The compounds are also
Partial and full agonists of A.sub.1 adenosine receptors
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including modifying cardiac activity, in particular treatment of arrhythmia. The compounds are also
Partial and full agonists of A.sub.1 adenosine receptors
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including cardiovascular diseases, in particular arrhythmia, and the prevention of sudden death
4-anilinoquinazoline derivatives with adenosine-kinase inhibitor properties
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
This invention relates to compounds derived from 4-anilinoquinazolines that present adenosine-kinase inhibitory activity and use thereof in diseases or conditions that are benefited from the adenosine kinase inhibition. More particularly, the present invention relates to the
Partial and full agonists of A.sub.1 adenosine receptors
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to novel compounds that are partial or full A.sub.1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including cardiovascular diseases, in particular arrhythmia, and the prevention of sudden death
O mais completo banco de dados de ervas medicinais apoiado pela ciência
- Funciona em 55 idiomas
- Curas herbais apoiadas pela ciência
- Reconhecimento de ervas por imagem
- Mapa GPS interativo - marcar ervas no local (em breve)
- Leia publicações científicas relacionadas à sua pesquisa
- Pesquise ervas medicinais por seus efeitos
- Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes
Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas
